Biobetters are just a nickname; they’re based on existing biologics but with a few key differences

Oncology Insights Oncology Case Management and Navigation: How do they differ? Caring for and treating a patient with cancer is complex. Many patients struggle to coordinate therapy, manage...

50M Footnotes As many as 50M people in the United States have an autoimmune disease, making it the third most prevalent disease category, surpassed only by cancer and heart disease.2 Unlock...

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

Evaluating Case Management Referral Patterns: Insights From an Enhanced Utilization anagement Program Real-World Patterns of On-Demand Therapy Utilization Following Initiation of Long-Term...

High Cost Therapy Profile Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) Gene Therapy/Immunology Marnetegragene autotemcel...

Reimagine your pharmacy benefit partner Get expert insights Go Somewhere Save, Simplify, Support™ Biologic drugs are transforming lives for the better, yet often at a substantial cost. Biosimilars,...

For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories

research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies Evaluating the 10-Year Impact of an...

Insert Link Medical Formulary Strategy ensures the most appropriate and clinically effective medical benefit drugs are evaluated with product-preferencing strategies, for all lines of business....

Weight loss Support and empower weight loss in a healthy, manageable and sustainable way with customized paths for each member. Medication management Improve drug adherence or reduce the number of...

Flexible, cost-effective, strategic partnership Specialty drugs have changed the pharmacy landscape over the past decade and now represent more than half of total drug spend. Having a strong...

Clinical deep dive Disease state overview WAS is a rare, X-linked, genetic disorder characterized by thrombocytopenia, eczema, immunodeficiency, and increased risk of autoimmunity and...

All brand names are property of their respective owners. References Kim SY, Park HS, Chiang AC. Small Cell Lung Cancer: A Review. JAMA. 2025;333(21):1906-1917. doi:10.1001/jama.2025.0560...

Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these impactful and potentially practicing changing subjects that are likely...

Marquee event showcased new Prime, our energy, ambition and transformative journey

May 22, 2025 – mepolizumab (Nucala) GlaxoSmithKline; an IL-5 antagonist monoclonal antibody New indication: add-on maintenance treatment of adults with inadequately controlled chronic obstructive...

Medication Nonadherence Social Determinants of Health Risk Score: Development and Use 2024 AMCP Annual Posters Real-World First Year Cost-Effectiveness Assessment of Glucagon-Like Peptide-1...

Clinical deep dive Disease state overview Myelodysplastic syndromes (MDS) are classified as disorders in which there are abnormal (dysplastic) hematopoietic stem cells in the bone marrow, leading...

Prime is pleased to present the seventh edition of the Employer Market Insights Report. Within this one-of-a-kind publication, you’ll find critical pharmacy trend insights that will help you make...

Speaking Engagements Learn more Yuqian Liu and Camile Rabe & Tim O'Shea, Horizon Mission Impossible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management with Prime's...

Event features discussions about health care industry trends, best practices and innovations

Clinical deep dive Disease state overview MacTel type 2 is a rare neurodegenerative disease that affects the macula, which processes central and color vision. It is a bilateral asymmetric...

Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 References PTC Therapeutics announces FDA acceptance and Priority Review of the BLA for UpstazaTM. PTC...

Home Our solutions Modern technology MyRxInsights Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and...

Drs. Tracey Garcia and Amy Pappas, board-certified neurologists, reviewed migraine risk factors and treatments in a recent webinar moderated by Dr. Marci Chodroff, vice president of medical affairs

When you fill your specialty prescription, we automatically enroll you in our Care Specialists program. Our care specialists are pharmacists and nurses who are specially trained in your condition....

Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators The purpose of the study was to create a methodological framework for using propensity score...

Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab Oncology Linvoseltamab, intravenous (IV) Regeneron Pharmaceuticals Proposed indications...

Empowering client, providers and members 2024: Using real-time pricing, Pharmacy Match drives affordability for plan sponsors while offering access to the most competitive pharmacy for each member....

NMPI: National Medicaid Pooling Initiative We negotiate the best price available from the pharmaceutical industry on behalf of our participating clients. View resources Services we offer Our...

Whitepaper Tab 1 Myth 1 Myth 2 Myth 3 Myth 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed nec ornare mi. Praesent ultrices ipsum eget est rutrum, eget congue orci molestie. Sed diam...

PUBLICATIONS FDA Decisions Expected: May 2026 Your monthly synopsis of new drugs expected to hit the market Bio-Thera is awaiting FDA decision for BAT2506, a golimumab biosimilar candidate to...

cover image Explore emerging cell and gene therapies, rare disease innovation and payer strategies shaping the specialty pipeline. Prime Therapeutics /spring-2026-prime-therapeutics-report The...

Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

Senior Account Manager - Remote Investment Accountant, Principal - Remote Job description: The Senior Financial Application Analyst is responsible for the administration of the Hyperion application...

The autologous, engineered cell therapy by Abeona, prademagene zamikeracel, has been resubmitted to the FDA for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). This is the...

Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.

Join us and help reimagine pharmacy benefit management to provide the same care you would want for your loved ones. Check out our Careers page to see additional job listings, benefits and more....

References Sadelain M. Engineering the future – innovation in CAR T therapy design. Presented at Precision Medicine World Conference. March 4, 2026: Santa Clara, CA. Harris E, June C, Sadelain M....